Apyx Medical Corp Quarterly Deferred Income Tax Expense (Benefit) in USD from Q2 2010 to Q1 2017
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Apyx Medical Corp annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q1 2017.
- Apyx Medical Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2017 was $0.000.
- Apyx Medical Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$4.38M, a 14.2% increase from 2022.
- Apyx Medical Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$5.1M, a 62.9% decline from 2021.
- Apyx Medical Corp annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.13M, a 204% decline from 2020.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)